LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test ...

PracticeQ and Fullscript partner to simplify lab ordering and results management, helping providers deliver faster, more connected care.

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a ...

Company expands its ecosystem of investors with new financing from InHealth Ventures, part of a large UK-based health system, and the Labcorp Venture Fund IMVARIA Inc., a health tech company pioneerin ...

Cellens, a Boston, MA-based cancer diagnostics startup, has raised a $6.5 million seed round. The company is developing a mechanobiology and AI-driven platform, BioFeel, for non-invasive cancer ...

Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks Cofactor Genomics, a ...

Analysts have set 12-month price targets for Fortrea Holdings, revealing an average target of $15.5, a high estimate of $25.00, and a low estimate of $9.00. This upward trend is evident, with the ...

Profound Medical Corp. ("Profound" or the "Company") is pleased to announce that it has completed its previously announced private placement of common shares to Canadian investors (the "Offering").